Differences in clinical features between influenza A H1N1, A H3N2, and B in adult patients.
about
The genomic and epidemiological dynamics of human influenza A virusComparative analyses of pandemic H1N1 and seasonal H1N1, H3N2, and influenza B infections depict distinct clinical pictures in ferretsPrevalence of gastrointestinal symptoms in patients with influenza, clinical significance, and pathophysiology of human influenza viruses in faecal samples: what do we know?Competitive Fitness of Influenza B Viruses Possessing E119A and H274Y Neuraminidase Inhibitor Resistance-Associated Substitutions in FerretsLymphocyte to monocyte ratio as a screening tool for influenzaClinical Characteristics Are Similar across Type A and B Influenza Virus Infections.Emergence of pandemic 2009 influenza A H1N1, India.Simultaneous investigation of influenza and enteric viruses in the stools of adult patients consulting in general practice for acute diarrheaInfluenza HA subtypes demonstrate divergent phenotypes for cleavage activation and pH of fusion: implications for host range and adaptationAge distribution of influenza like illness cases during post-pandemic A(H3N2): comparison with the twelve previous seasons, in France.The clinical usefulness of lymphocyte:monocyte ratios in differentiating influenza from viral non-influenza-like illnesses in hospitalized adults during the 2015 influenza A (H3N2) epidemic: the uniqueness of HPIV-3 mimicking influenza A.Clinical differences of influenza subspecies among hospitalized childrenImproving the clinical diagnosis of influenza--a comparative analysis of new influenza A (H1N1) casesRNA Viruses: ROS-Mediated Cell Death.Age dependent differences in the kinetics of γδ T cells after influenza vaccination.Clinical and socioeconomic impact of different types and subtypes of seasonal influenza viruses in children during influenza seasons 2007/2008 and 2008/2009.The genomic rate of molecular adaptation of the human influenza A virusSeasonal influenza A virus in feces of hospitalized adults.Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge ModelAge-specific differences in influenza virus type and subtype distribution in the 2012/2013 season in 12 European countries.Higher polymerase activity of a human influenza virus enhances activation of the hemagglutinin-induced Raf/MEK/ERK signal cascade.Retrospective review of factors associated with severe hospitalised community-acquired influenza in a tertiary paediatric hospital in South Australia.MISSEL: a method to identify a large number of small species-specific genomic subsequences and its application to viruses classification.The presence of fever in adults with influenza and other viral respiratory infections.Impact of a large deletion in the neuraminidase protein identified in a laninamivir-selected influenza A/Brisbane/10/2007 (H3N2) variant on viral fitness in vitro and in ferrets.A Bayesian System to Detect and Characterize Overlapping Outbreaks.Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15.A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single-Ascending-Dose Study To Investigate the Safety, Tolerability, and Pharmacokinetics of an Anti-Influenza B Virus Monoclonal Antibody, MHAB5553A, in Healthy Volunteers.Pathogenic influenza B virus in the ferret model establishes lower respiratory tract infection.Retrospective Observational Study of Atypical Winter Respiratory Illness Season Using Real-Time Syndromic Surveillance, England, 2014-15Disparities in spread and control of influenza in slums of Delhi: findings from an agent-based modelling study.
P2860
Q24649077-8116B817-D30A-4C5D-B478-BDE898FE70D6Q27312721-CD2A6008-EADE-40BE-BAA0-E18F812CCE3FQ28083816-54187A22-D5B5-4841-A66E-0C01D83052B7Q28553195-C37E80F2-F44F-4EC3-92A8-688A4C05596BQ28972265-82A1BF7A-679A-48EA-A534-C48CC6093DE7Q30378619-875D0207-0116-42E9-BC99-873ECDFC35A5Q30417543-C50E5421-91DB-4DC2-AFF1-8A329BC0B39DQ30418175-8376A71D-DA83-454F-9D6E-6A05E4E6C186Q30427818-3D888C96-D206-4DAF-93FB-4D8353997777Q30431735-B71228B3-C240-46F8-8E32-3E433A45319CQ33427524-8A41E378-9111-45A2-91B6-D58E9B2077F1Q33441325-9CD7EA47-BF53-4298-8DF4-FC7B498BFDF7Q33521204-F419E7BC-7B9A-43D7-8C23-8208D3043979Q33668416-1B17F733-5C34-4064-8414-CC3ACD0F4F0FQ33898222-4E44E716-7C44-4354-8598-FA01E3DF3B38Q34047266-B8A647DC-DD11-4E0C-A45B-4C1D9AFBFFBDQ34171512-85AE9252-56FF-42AD-8227-09B7896317F5Q35847198-C57699DA-00F3-46B4-BB2A-88784DC56D6CQ35892839-2B6274C9-31C0-4ADF-8E86-1E9B154A373FQ36129250-D006F22B-E286-48E8-A327-3E0F52CDC085Q36419847-E052D391-FB93-4D7C-97B8-29492CA9EB1AQ37331088-A21B0447-893C-442F-962E-44519904BC0DQ37476369-B967C9E7-9605-4768-8C4E-B3916B8FD096Q37542150-61154D55-9A1E-48AC-8FD6-53AA04B899FDQ38298912-C9DBC08A-E502-4B2D-B26A-F9742A45EAA6Q38630006-0D69E897-B5D7-40A4-90D2-2738789E6877Q39961932-76BD6DE0-764F-48F7-B67C-1951BDD873ECQ40180049-68822AC2-C4E4-4230-A109-6D5B790F77E9Q42208634-447BAB73-F9C6-46F1-B0D2-01CBDDCC68BFQ42650298-FFEE2F16-DF05-441C-977D-ADDD25887FF0Q47555819-B03271C3-B1C4-4AD0-8B5A-D7AFF2F1521C
P2860
Differences in clinical features between influenza A H1N1, A H3N2, and B in adult patients.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Differences in clinical featur ...... H3N2, and B in adult patients.
@en
type
label
Differences in clinical featur ...... H3N2, and B in adult patients.
@en
prefLabel
Differences in clinical featur ...... H3N2, and B in adult patients.
@en
P2093
P1433
P1476
Differences in clinical featur ...... H3N2, and B in adult patients.
@en
P2093
Aya Watanabe
Hisamichi Aizawa
Masahide Kaji
P2860
P304
P356
10.1046/J.1440-1843.2003.00457.X
P577
2003-06-01T00:00:00Z